Canadian-built laser chills antimatter to near absolute zero for first time

Researchers with the CERN-based ALPHA collaboration have announced the world’s first laser-based manipulation of antimatter, leveraging a made-in-Canada laser system to cool a sample of antimatter down to near absolute zero. The achievement,...
30-Mar-2021 12:45 PM EDT Add to Favorites

Dr. Nigel Smith appointed as next Director of TRIUMF

Dr. Nigel Smith has been selected to serve as the next Director of TRIUMF.
12-Feb-2021 10:30 AM EST Add to Favorites

TRIUMF spin-off company secures US$19M investment

ARTMS Inc., TRIUMF spin-off company and global leader in isotope production technology, has announced US$19 million in Series A financing from a consortium led by Deerfield Management Company and Quark Ventures.
21-May-2020 9:00 AM EDT Add to Favorites

TRIUMF receives historic investment in 2019 federal budget

Building on a 50-year legacy of accelerating science for research, medicine, and business, TRIUMF today received an historic $292.7M investment in support of the lab’s future and its vision for Canada.
19-Mar-2019 5:00 PM EDT Add to Favorites

TRIUMF Theory Helps Shed New Light on Thermonuclear Fusion of Deuterium and Tritium

Scientists at TRIUMF, the Institut de Physique Nucléaire, and Lawrence Livermore National Laboratory have for the first time accurately predicted the properties of polarized deuterium-tritium thermonuclear fusion. Their findings, described in a...
28-Jan-2019 1:05 PM EST Add to Favorites

Prime Minister of Canada Announces Establishment of Premier Centre for Advanced Medical IsotopeResearch and Development at TRIUMF

This afternoon, TRIUMF welcomed on-site The Right Honourable Justin Trudeau, Prime Minister of Canada, for a special visit and announcement about public investments into medical isotope research and innovation infrastructure.
1-Nov-2018 6:00 PM EDT Add to Favorites

TRIUMF Launches New Five-Year Plan 2020-2025

TRIUMF, Canada’s particle accelerator centre, is pleased to launch its new Five-Year Plan 2020-2025, developed with extensive internal and external community consultation. It leverages past investments by government and builds on the...
9-Oct-2018 9:30 AM EDT Add to Favorites

TRIUMF and CNL Form Strategic Partnership to Enable Ground-Breaking Cancer Treatment

TRIUMF, Canada’s particle accelerator centre, and Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, are pleased to announce that they have agreed to pursue a strategic partnership around the...
27-Sep-2018 9:30 AM EDT Add to Favorites

See All News